Russian anxiolytic heptapeptide.
Selank is a synthetic heptapeptide anxiolytic developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Officially registered as a medicinal product in Russia, it represents a distinct approach to anxiolysis compared to benzodiazepines. Supplied as research-grade material with 3rd-party HPLC verification and full Certificate of Analysis per lot.
Selank is a synthetic heptapeptide anxiolytic developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Officially registered as a medicinal product in Russia, it represents a distinct approach to anxiolysis compared to benzodiazepines.
Published literature (primarily Russian) describes anxiolytic effects without sedation or dependence potential characteristic of benzodiazepines. Proposed mechanisms include GABA-ergic modulation, BDNF upregulation, and modulation of monoamine neurotransmitter systems.
Registered and prescribed in Russia for generalized anxiety disorder. Not FDA-approved. Widely available outside Russia as a research compound. Often administered intranasally in both research and clinical Russian use.
The above summarizes published research literature. This is not medical advice, a protocol, or a recommendation for use. This compound is supplied for laboratory research only.
Selank is a 7-residue peptide with molecular formula C33H57N11O9 and molecular weight of approximately 751.9 Da.
The full structural data and release specifications are in the Compound Profile section above. Every lot ships with an independently verified Certificate of Analysis.
Each lot is independently verified by a 3rd-party analytical laboratory (STERIS Labs, Alcami Analytical, or equivalent) before release. Release specification is HPLC purity ≥ 99.5% (typical > 99.8%), mass spectrometry identity match within ±0.5 Da, water content < 5.0% Karl Fischer, and endotoxin < 0.25 EU/mL by LAL (USP <85>).
Look up the full COA for your lot at coa-lookup.html.
All compounds ship at ambient temperature in discreet, tamper-evident packaging. Lyophilized peptide powder is stable at room temperature for typical transit windows, which is why research-grade vendors ship this way. Tracked; signature not required.
Store unopened lyophilized product at 2–8°C protected from light. Once reconstituted, most peptides are stable at 2–8°C for approximately 28 days (compound-dependent).
Registered and prescribed in Russia for generalized anxiety disorder. Not FDA-approved. Widely available outside Russia as a research compound. Often administered intranasally in both research and clinical Russian use.
All PeptideBros compounds are sold strictly as chemical reference materials for in-vitro laboratory research. They are not for human consumption.
HPLC-verified. Mass-spec confirmed. Ambient-stable transit. The paperwork other vendors hope you never ask for.